The Lurie Cancer Center has a well-developed system for planning and evaluation, the foundation of which is a formal strategic plan. The four major governance structures ofthe Lurie Cancer Center provide the primary means by which the Director and Senior Leadership conduct planning and evaluation on an ongoing basis, consistent with the strategic plan. The governance structures include the Executive Committee, the Center's primary policy and decision-making group, which coordinates overall planning efforts. Providing input to the Executive Committee are the Leadership Group, and the Internal and External Advisory Boards. The Leadership Group includes the Executive Committee and all Program and Shared Resource leaders/directors and meets quarterly to review and provide progress and input for research programs, shared resources and training/education. The Internal Advisory Board includes the Center Director, Deputy Director and Administrator;the Dean and other senior leaders of the Feinberg School of IVIedicine, Northwestern Memorial Hospital, Northwestern Medical Faculty Foundation, and Northwestern University;and key Department Chairs and Center/Institute Directors;and meets semi-annually to provide institution wide perspective and guidance to the Lurie Cancer Center Director. The External Advisory Board is comprised of recognized leaders in clinical, basic and population sciences, biostatistics and center administration as well as a patient advocate representative, and meets annually to review all aspects of Center operations. Additional planning input is provided by retreats, other Center advisory committees, surveys and ad hoc reviews. CCSG support is requested only for the activities of the External Advisory Board which plays an essential role in the evaluation ofthe Lurie Cancer Center's programs, activities, structure and organization.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Northwestern University at Chicago
United States
Zip Code
Caralt, M; Uzarski, J S; Iacob, S et al. (2015) Optimization and critical evaluation of decellularization strategies to develop renal extracellular matrix scaffolds as biological templates for organ engineering and transplantation. Am J Transplant 15:64-75
Gach, Johannes S; Achenbach, Chad J; Chromikova, Veronika et al. (2014) HIV-1 specific antibody titers and neutralization among chronically infected patients on long-term suppressive antiretroviral therapy (ART): a cross-sectional study. PLoS One 9:e85371
Hung, Andy H; Holbrook, Robert J; Rotz, Matthew W et al. (2014) Graphene oxide enhances cellular delivery of hydrophilic small molecules by co-incubation. ACS Nano 8:10168-77
Keller, Jacob Pearson; Homma, Kazuaki; Duan, Chongwen et al. (2014) Functional regulation of the SLC26-family protein prestin by calcium/calmodulin. J Neurosci 34:1325-32
Zhao, Baobing; Keerthivasan, Ganesan; Mei, Yang et al. (2014) Targeted shRNA screening identified critical roles of pleckstrin-2 in erythropoiesis. Haematologica 99:1157-67
Jensen, Samuel A; Calvert, Andrea E; Volpert, Giora et al. (2014) Bcl2L13 is a ceramide synthase inhibitor in glioblastoma. Proc Natl Acad Sci U S A 111:5682-7
Daugherty, Rebecca L; Serebryannyy, Leonid; Yemelyanov, Alex et al. (2014) ?-Catenin is an inhibitor of transcription. Proc Natl Acad Sci U S A 111:5260-5
Anderson, Mark T; Dewenter, Lena; Maier, Berenike et al. (2014) Seminal plasma initiates a Neisseria gonorrhoeae transmission state. MBio 5:e01004-13
Cull, Elizabeth H; Altman, Jessica K (2014) Contemporary treatment of APL. Curr Hematol Malig Rep 9:193-201
Brahmer, J R; Lee, J W; Traynor, A M et al. (2014) Dosing to rash: a phase II trial of the first-line erlotinib for patients with advanced non-small-cell lung cancer an Eastern Cooperative Oncology Group Study (E3503). Eur J Cancer 50:302-8

Showing the most recent 10 out of 316 publications